Narrative reviewindependent cross-checkabstract checked I-SYS-106 standard review

Prolonged water fasting: short-term effects only

Efficacy and safety of prolonged water fasting: a narrative review of human trials.

Overview

Ezpeleta M et al.. Nutr Rev 2024 · PMID 37377031 · DOI 10.1093/nutrit/nuad081

Fasting 5-20 days lowered weight and blood pressure, but two-thirds of weight lost was lean mass and benefits faded.

Does the study support the specific claim? No · Methodological quality: low

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Review prolonged fasting.

How was the study done?

Narrative review.

How many people, animals or samples were studied?

Human trials.

What was actually found?

Short-term changes, lean-mass loss.

How large was the observed effect?

2-10% weight loss.

What do the results mean in everyday life?

Not eating does not create lasting health.

What are the study's limitations?

Small trials.

What does it say about Elawady's specific claim?

Contradicts the claim.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Long-term outcomes.

Scientific in-depth review

1. Full reference

Authors
Ezpeleta M et al.
Journal
Nutr Rev
Year
2024
Identifier
PMID 37377031 DOI 10.1093/nutrit/nuad081
Verification
verified – PubMed efetch 2026-10-26 + Crossref
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

NIH grant (PubMed)

2. Research question

Efficacy and safety of prolonged water fasting (5-20 days)

3. Study design and population

Study design
Narrative review – Narrative review of human trials of prolonged water fasting
Population

Human trial participants

Country

International

Period

Published 2024

Sample size

not stated in abstract

Inclusion and exclusion criteria

Human trials

4. Methods and endpoints

Exposure / intervention

Prolonged water fasting

Comparator

Baseline/controls

Endpoints

Weight, BP, lipids, glycaemia, adverse events

Statistical methods

Narrative

5. Actual results

Results

Weight loss 2-10%, about two-thirds lean mass; BP decreased; lipids inconsistent; glycaemic markers improved in normoglycaemic adults but unchanged in type 1/2 diabetes; benefits disappeared 3-4 months after refeeding; adverse events included metabolic acidosis, headaches, insomnia, hunger.

Absolute risks

not applicable

Authors' conclusion

Prolonged fasting appears moderately safe and produces weight loss; sustained metabolic benefit uncertain.

6. Strengths

  • Collects human trial data

7. Weaknesses

  • Narrative
  • Small trials

8. Risk of bias

Orienting tool
none applicable
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
not assessable
Rationale

Narrative review.

9. Assessment of the statistical interpretation

Not applicable.

10. Relevance to the specific claim

Shows that going without food has some short-term metabolic effects but costs lean mass and does not produce lasting health.

11. Independent contrary findings

Supports that supervised short fasting can be tolerated - a limited kernel.

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Contradicts 'zero inputs = infinite health'.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitylow
Risk of biasnot assessable
Precision of resultsnot applicable
Directnessindirect
Reproducibilityunknown
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks